Supporting this, rat models of apatinib-induced hypertension exhibit upregulation of RhoA and ROCK2 in the mid-aorta, accompanied by reduced MLCP activity and increased ET-1 and collagen I expression. This evidence concerns the gene RHOA and Hypertension.